PFG Private Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-40
Closed -$2.71K 98
2025
Q1
$2.71K Hold
40
﹤0.01% 219
2024
Q4
$1.8K Sell
40
-13
-25% -$729 ﹤0.01% 199
2024
Q3
$3.33K Hold
53
﹤0.01% 182
2024
Q2
$3.13K Sell
53
-262
-83% -$16.4K ﹤0.01% 181
2024
Q1
$25.1K Hold
315
0.02% 108
2023
Q4
$24.9K Hold
315
0.02% 101
2023
Q3
$22K Sell
315
-385
-55% -$27.3K 0.02% 162
2023
Q2
$48.4K Hold
700
0.03% 149
2023
Q1
$52K Sell
700
-502
-42% -$42.1K 0.03% 148
2022
Q4
$112K Buy
1,202
+472
+65% +$45.5K 0.07% 79
2022
Q3
$70K Sell
730
-2,136
-75% -$211K 0.05% 122
2022
Q2
$266K Sell
2,866
-711
-20% -$69.4K 0.15% 41
2022
Q1
$362K Sell
3,577
-1,130
-24% -$119K 0.19% 38
2021
Q4
$486K Buy
4,707
+154
+3% +$14.2K 0.25% 34
2021
Q3
$386K Buy
4,553
+106
+2% +$8.88K 0.23% 36
2021
Q2
$371K Buy
4,447
+652
+17% +$53.4K 0.24% 36
2021
Q1
$285K Buy
+3,795
New +$276K 0.2% 38
2020
Q3
Sell
-5,324
Closed -$346K 47
2020
Q2
$346K Buy
+5,324
New +$335K 0.33% 36

Other funds holding CVS

PFG Private Wealth Management's CVS Position: Q2 2025 in Review

PFG Private Wealth Management sold out of CVS Health (CVS) in Q2 2025, closing a stake of 40 shares — an estimated $2.71K sold.

PFG Private Wealth Management first reported a position in CVS in Q2 2020 and held it in 18 quarters. The position peaked at $486K in Q4 2021. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • PFG Private Wealth Management reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • PFG Private Wealth Management sold 40 CVS Health shares in Q2 2025, an estimated $2.71K.
  • PFG Private Wealth Management first reported a position in CVS Health in Q2 2020 and held it in 18 quarters.
  • PFG Private Wealth Management's CVS Health position peaked at $486K in Q4 2021.
  • 1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on PFG Private Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.